• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将抗菌药物耐药性监测与医疗机构中的抗生素政策联系起来:COMBACTE-Magnet EPI-Net COACH 项目。

Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project.

机构信息

Infectious Diseases Section, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.

Bonn University Hospital, Institute for Hygiene and Public Health, Bonn, Germany.

出版信息

J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii2-ii19. doi: 10.1093/jac/dkaa425.

DOI:10.1093/jac/dkaa425
PMID:33280049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7719409/
Abstract

OBJECTIVES

To systematically summarize the evidence on how to collect, analyse and report antimicrobial resistance (AMR) surveillance data to inform antimicrobial stewardship (AMS) teams providing guidance on empirical antibiotic treatment in healthcare settings.

METHODS

The research group identified 10 key questions about the link between AMR surveillance and AMS using a checklist of 9 elements for good practice in health research priority settings and a modified 3D combined approach matrix, and conducted a systematic review of published original studies and guidelines on the link between AMR surveillance and AMS.

RESULTS

The questions identified focused on AMS team composition; minimum infrastructure requirements for AMR surveillance; organisms, samples and susceptibility patterns to report; data stratification strategies; reporting frequency; resistance thresholds to drive empirical therapy; surveillance in high-risk hospital units, long-term care, outpatient and veterinary settings; and surveillance data from other countries. Twenty guidelines and seven original studies on the implementation of AMR surveillance as part of an AMS programme were included in the literature review.

CONCLUSIONS

The evidence summarized in this review provides a useful basis for a more integrated process of developing procedures to report AMR surveillance data to drive AMS interventions. These procedures should be extended to settings outside the acute-care institutions, such as long-term care, outpatient and veterinary. Without proper AMR surveillance, implementation of AMS policies cannot contribute effectively to the fight against MDR pathogens and may even worsen the burden of adverse events from such interventions.

摘要

目的

系统总结有关如何收集、分析和报告抗菌药物耐药性(AMR)监测数据的证据,为在医疗保健环境中提供经验性抗生素治疗指导的抗菌药物管理(AMS)团队提供信息。

方法

研究小组使用健康研究优先领域的 9 项良好实践要素清单和改良的 3D 综合方法矩阵确定了 10 个有关 AMR 监测与 AMS 之间联系的关键问题,并对 AMR 监测与 AMS 之间联系的已发表原始研究和指南进行了系统评价。

结果

确定的问题集中在 AMS 团队组成;AMR 监测的最低基础设施要求;报告的生物体、样本和药敏模式;数据分层策略;报告频率;驱动经验性治疗的耐药阈值;高风险医院单位、长期护理、门诊和兽医环境中的监测;以及来自其他国家的监测数据。对 AMR 监测作为 AMS 计划的一部分的实施的 20 项指南和 7 项原始研究被纳入文献综述。

结论

本综述中总结的证据为更综合的过程提供了有用的基础,以便制定报告 AMR 监测数据以驱动 AMS 干预的程序。这些程序应扩展到急性护理机构以外的环境,如长期护理、门诊和兽医。如果没有适当的 AMR 监测,AMS 政策的实施就不能有效地对抗 MDR 病原体,甚至可能使此类干预措施的不良事件负担恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85bb/7719409/e9a62862ef72/dkaa425f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85bb/7719409/e9a62862ef72/dkaa425f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85bb/7719409/e9a62862ef72/dkaa425f1.jpg

相似文献

1
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project.将抗菌药物耐药性监测与医疗机构中的抗生素政策联系起来:COMBACTE-Magnet EPI-Net COACH 项目。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii2-ii19. doi: 10.1093/jac/dkaa425.
2
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合动物领域监测数据与抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实践指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii52-ii66. doi: 10.1093/jac/dkaa429.
3
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合长期护理机构监测数据与抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实用指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii33-ii41. doi: 10.1093/jac/dkaa427.
4
White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合人类和动物监测数据、医院部门抗生素政策和管理之间的差距 - JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实用指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii20-ii32. doi: 10.1093/jac/dkaa426.
5
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合监测数据与门诊部门抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实践指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii42-ii51. doi: 10.1093/jac/dkaa428.
6
Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.埃及、伊拉克、约旦和黎巴嫩的抗微生物药物耐药性现状和 COVID-19 影响:一项基于调查的研究和专家意见。
PLoS One. 2023 Jul 27;18(7):e0288550. doi: 10.1371/journal.pone.0288550. eCollection 2023.
7
Is the education of human and animal healthcare professionals about antimicrobial resistance and stewardship adequate during their pre-service training?在人类和动物医疗保健专业人员的职前培训期间,关于抗菌药物耐药性和管理的教育是否足够?
Indian J Med Microbiol. 2021 Oct-Dec;39(4):439-445. doi: 10.1016/j.ijmmb.2021.08.458. Epub 2021 Sep 10.
8
Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review.COVID-19 大流行前后急性护理环境中抗菌药物管理的实施:系统评价。
BMC Public Health. 2023 Feb 10;23(1):309. doi: 10.1186/s12889-023-15072-5.
9
Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).预防抗菌药物耐药和医源性感染的实施研究;2017 年日内瓦感染预防和控制(IPC)-智库(第 1 部分)。
Antimicrob Resist Infect Control. 2019 May 28;8:87. doi: 10.1186/s13756-019-0527-1. eCollection 2019.
10
Mechanisms affecting the implementation of a national antimicrobial stewardship programme; multi-professional perspectives explained using normalisation process theory.影响国家抗菌药物管理计划实施的机制;使用规范过程理论解释多专业视角。
Antimicrob Resist Infect Control. 2020 Jul 2;9(1):99. doi: 10.1186/s13756-020-00767-w.

引用本文的文献

1
Multidrug-Resistant in Diabetic Foot Infections (DFI) from Beira, Mozambique: Prevalence and Virulence Profile.莫桑比克贝拉糖尿病足感染(DFI)中的多重耐药性:患病率和毒力特征
Infect Drug Resist. 2025 May 31;18:2779-2796. doi: 10.2147/IDR.S521876. eCollection 2025.
2
Antibiotic resistance and molecular characterization of non-invasive clinical isolates in Germany 2019 and 2020.2019年和2020年德国非侵袭性临床分离株的抗生素耐药性及分子特征
JAC Antimicrob Resist. 2024 Dec 10;6(6):dlae197. doi: 10.1093/jacamr/dlae197. eCollection 2024 Dec.
3
Protocol for surveillance of antimicrobial-resistant bacteria causing community-acquired urinary tract infections in low-income countries.

本文引用的文献

1
European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines.欧洲泌尿外科学会泌尿感染指南:2024 年指南摘要。
Eur Urol. 2024 Jul;86(1):27-41. doi: 10.1016/j.eururo.2024.03.035. Epub 2024 May 6.
2
Clinical Decision Support Systems and Their Role in Antibiotic Stewardship: a Systematic Review.临床决策支持系统及其在抗生素管理中的作用:一项系统综述。
Curr Infect Dis Rep. 2019 Jul 24;21(8):29. doi: 10.1007/s11908-019-0683-8.
3
Global geographic trends in antimicrobial resistance: the role of international travel.
针对低收入国家社区获得性尿路感染中抗菌耐药菌的监测方案。
PLoS One. 2024 May 31;19(5):e0304388. doi: 10.1371/journal.pone.0304388. eCollection 2024.
4
Determination of the Enablers and Challenges in the Implementation of Pharmacy-based Antimicrobial Stewardship (AMS) Program in a Level 3 Hospital in Manila.马尼拉一家三级医院实施基于药房的抗菌药物管理(AMS)计划的推动因素与挑战的确定
Acta Med Philipp. 2024 May 15;58(8):50-66. doi: 10.47895/amp.vi0.6658. eCollection 2024.
5
Evaluation of Hospital Antimicrobial Stewardship Programs: Implementation, Process, Impact, and Outcomes, Review of Systematic Reviews.医院抗菌药物管理计划评估:实施、过程、影响及结果,系统评价综述
Antibiotics (Basel). 2024 Mar 12;13(3):253. doi: 10.3390/antibiotics13030253.
6
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach.《EPI-Net 一体化健康抗菌药物使用与耐药性监测数据报告指南:德尔菲法》
Lancet Reg Health Eur. 2022 Dec 22;26:100563. doi: 10.1016/j.lanepe.2022.100563. eCollection 2023 Mar.
7
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合动物领域监测数据与抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实践指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii52-ii66. doi: 10.1093/jac/dkaa429.
8
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合长期护理机构监测数据与抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实用指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii33-ii41. doi: 10.1093/jac/dkaa427.
9
White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合人类和动物监测数据、医院部门抗生素政策和管理之间的差距 - JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实用指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii20-ii32. doi: 10.1093/jac/dkaa426.
10
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.白皮书:弥合监测数据与门诊部门抗菌药物管理之间的差距——JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的实践指南。
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii42-ii51. doi: 10.1093/jac/dkaa428.
全球抗菌药物耐药性的地理趋势:国际旅行的作用。
J Travel Med. 2019 Dec 23;26(8). doi: 10.1093/jtm/taz036.
4
A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.一种非线性时间序列分析方法,用于确定人群抗生素使用与耐药率之间关联的阈值。
Nat Microbiol. 2019 Jul;4(7):1160-1172. doi: 10.1038/s41564-019-0410-0. Epub 2019 Apr 8.
5
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017.急性护理医院和长期护理机构中与医疗保健相关的感染、估计发病率和综合抗菌药物耐药指数的流行情况:来自 2016 年至 2017 年两项欧洲患病率调查的结果。
Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.2018.23.46.1800516.
6
Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study.产超广谱β-内酰胺酶肠杆菌科的携带情况与结直肠手术后手术部位感染的风险:一项前瞻性队列研究。
Clin Infect Dis. 2019 May 2;68(10):1699-1704. doi: 10.1093/cid/ciy768.
7
Present and Future Surveillance of Antimicrobial Resistance in Animals: Principles and Practices.动物抗菌药物耐药性的现状和未来监测:原则与实践。
Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0028-2017.
8
Travel and acquisition of multidrug-resistant Enterobacteriaceae.旅行和获得耐多药肠杆菌科细菌。
Med Mal Infect. 2018 Oct;48(7):431-441. doi: 10.1016/j.medmal.2018.02.005. Epub 2018 Mar 14.
9
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.治疗多重耐药革兰氏阴性菌引起的感染:英国抗菌化疗学会/医疗保健感染学会/英国感染协会联合工作组的报告。
J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027.
10
European Commission guidelines for the prudent use of antimicrobials in human health: a missed opportunity to embrace nursing participation in stewardship.欧盟委员会关于人类健康中谨慎使用抗菌药物的指南:错失了让护理人员参与管理的机会。
Clin Microbiol Infect. 2018 Aug;24(8):914-915. doi: 10.1016/j.cmi.2018.02.030. Epub 2018 Mar 2.